Your search for dabigatran returned 5 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove
Older than 2 years remove
MPR First Report remove

Your search for dabigatran returned 5 results

Sort Results:

Relevant Recent
American College of Cardiology 2011

Dabigatran Etexilate vs. Warfarin in Different Types of Atrial Fibrillation

A subgroup analysis from the RE-LY trial has demonstrated that in patients with atrial fibrillation (AF), twice-daily dabigatran etexilate has better efficacy and lower rates of major bleeding when compared with warfarin, as reported at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.
ASH 2010

Issues in Thrombosis Management and Anticoagulation

Novel oral anticoagulants, that do not require the laboratory monitoring associated with warfarin therapy, may alter the landscape of venous thromboembolism treatment and stroke prevention in atrial fibrillation, according to a study presented at the 52nd American Society of Hematology Meeting and Exposition.
American College of Cardiology 2011

Dabigatran Superior to Warfarin in Patients with Atrial Fibrillation and Lower CHA2DS2-VASc Scores

Dabigatran 150mg was superior to warfarin and dabigatran 110mg was noninferior to warfarin for preventing stroke in patients with atrial fibrillation (AF) regardless of CHA2DS2-VASc scores, as shown by the results of a subgroup analysis of the RE-LY trial presented today at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.
American College of Cardiology 2011

Supratherapeutic Dabigatran Does Not Prolong the QTc Interval

Supratherapeutic plasma levels of dabigatran etexilate do not prolong QTc intervals of the electrocardiogram (ECG), as reported from a study presented at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.